Financial impact on CVS due to DOJ lawsuit resolution by end of 2025
No significant impact • 25%
Minor financial penalties • 25%
Major financial penalties • 25%
Severe financial penalties • 25%
Financial reports from CVS, major financial news outlets
DOJ Sues CVS Health Corp. for Knowingly Filling Illegal Opioid Prescriptions Amid Nationwide Crisis
Dec 18, 2024, 11:45 PM
The U.S. Department of Justice has filed a lawsuit against CVS Health Corp., alleging that the pharmacy chain knowingly filled and billed federal health insurance programs for illegal opioid prescriptions, contributing to the nationwide opioid addiction and overdose crisis. The lawsuit claims that from October 17, 2013, to the present, CVS filled prescriptions for controlled substances that lacked a legitimate medical purpose, including dangerous quantities of opioids, early fills, and 'trinity' prescriptions, which combine an opioid, a benzodiazepine, and a muscle relaxant. The DOJ alleges that CVS ignored red flags and evidence from its own pharmacists and internal data, prioritizing corporate profits over patient safety. The lawsuit also accuses CVS of filling prescriptions from prescribers known to be engaged in 'pill mill practices,' where large numbers of controlled substance prescriptions are issued without a medical purpose. CVS, operating over 9,000 pharmacies across the U.S., has stated that it strongly disagrees with the allegations and will defend itself vigorously against the DOJ lawsuit.
View original story
Less than $500 million • 25%
No penalty • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Under $1 billion • 25%
Over $5 billion • 25%
$1 billion to $5 billion • 25%
No penalty • 25%
$500 million to $1 billion • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
Less than $500 million • 25%
CVS found guilty • 25%
CVS settles • 25%
Case dismissed • 25%
Other outcome • 25%
Ongoing litigation • 25%
CVS found liable • 25%
Less than $1 billion • 25%
$1 billion to $5 billion • 25%
More than $5 billion • 25%
No penalty • 25%
CVS found liable • 25%
Case dismissed • 25%
CVS not liable • 25%
CVS settles • 25%
Decrease by 0-5% • 25%
Decrease by over 5% • 25%
Increase by over 5% • 25%
Increase by 0-5% • 25%
Case dismissed • 25%
Walgreens wins • 25%
Settlement reached • 25%
DOJ wins • 25%
Case dismissed • 25%
Settlement reached • 25%
CVS found liable • 25%
CVS not found liable • 25%